Any question on childhood cancer?
The purpose of the Leucan Information Centre is to provide information to pediatric cancer patients and their parents.
12 August 2021
Pediatric ALL Relapse May Be Caused by Mutations From Chemotherapy
Although chemotherapy is the standard treatment for pediatric acute lymphoblastic leukemia (ALL), and has made it one of the most survivable childhood cancers, the chemotherapy drug class thiopurines can cause mutations that result in relapse. The findings were published in Nature Cancer.
10 August 2021
New research shows children with blood cancer at low risk of severe COVID-19 disease
Research published in the British Medical Journal’s Archives of Disease in Childhood has shown that children with haematological malignancies (blood cancers) are at no higher risk of severe COVID-19 disease than children with other types of cancer. Previously published research from this project had shown that overall, children with cancer were at no higher risk of severe disease as a result of infection by the SARS-CoV2 virus than healthy children.
03 August 2021
Life after St. Jude: ‘Cured’ Is Only the Beginning. One childhood cancer survivor learns to navigate life —and her health — after treatment.
Cured. For someone with cancer, the word elicits images of exultation, relief and celebration. But for most childhood cancer survivors, “cure” is not the end of the journey.
30 July 2021
Its comfort is not my responsibility
A young woman with a prosthetic leg hopes to make the world a more empathetic place. If only she didn’t have to do it during the first dates.
New resources
Supporting Marriages While Children are in Treatment
États-Unis,
Relapse – When Childhood Cancer Comes Back
États-Unis,
Anxiety
États-Unis,
Partners
Warning: Leucan Information Centre staff members do not possess medical, paramedical or psychosocial expertise. All information sources provided by the Leucan Information Centre are of a general nature and are complementary to the information already supplied by healthcare professionals. It is advisable that you address all of your specific, medical questions to these specialists. Leucan nor CHU Sainte-Justine do not endorse or accept any responsibility for contents supplied by the Leucan Information Centre.